Further, while the target surface proteins of cancer cells are often constitutively and highly expressed (e.g., breast cancers express 2 million HER2 molecules per cell) (21), primary cells usually have moderate to low target expression (e.g., 2500 PD-1 molecules per T cell) (unpublished data). This evidence concerns the gene ERBB2 and cancer.